• SENSEX
    NIFTY 50
Healthcare

Johnson & Johnson tops 1Q expectations on broad sales bump

Updated : April 17, 2018 05:28 PM IST

The New Brunswick, New Jersey, company reported net income of $4.37 billion, or $1.60 per share, down from $4.42 billion, or $1.81 per share, in 2017's first quarter.
Marketing and production costs were higher partly because of the launch of its new severe psoriasis drug, Tremfya, approved last summer.
The world's biggest maker of health care products reported that overseas sales jumped 20%, buoyed by favorable currency exchange rates.
Johnson & Johnson tops 1Q expectations on broad sales bump

You May Also Like

Live TV

recommended for you

Advertisement